CN1286459C - 一种含联苯苄唑的透明、隐形的外用药物制剂 - Google Patents
一种含联苯苄唑的透明、隐形的外用药物制剂 Download PDFInfo
- Publication number
- CN1286459C CN1286459C CN 200410039087 CN200410039087A CN1286459C CN 1286459 C CN1286459 C CN 1286459C CN 200410039087 CN200410039087 CN 200410039087 CN 200410039087 A CN200410039087 A CN 200410039087A CN 1286459 C CN1286459 C CN 1286459C
- Authority
- CN
- China
- Prior art keywords
- weight
- gel
- liniment
- total weight
- composition total
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 15
- 239000003814 drug Substances 0.000 title claims abstract description 12
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 16
- 239000000203 mixture Substances 0.000 claims description 76
- 229940040145 liniment Drugs 0.000 claims description 50
- 239000000865 liniment Substances 0.000 claims description 50
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 30
- OCAPBUJLXMYKEJ-UHFFFAOYSA-N 1-[biphenyl-4-yl(phenyl)methyl]imidazole Chemical compound C1=NC=CN1C(C=1C=CC(=CC=1)C=1C=CC=CC=1)C1=CC=CC=C1 OCAPBUJLXMYKEJ-UHFFFAOYSA-N 0.000 claims description 29
- 229960002206 bifonazole Drugs 0.000 claims description 29
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerol group Chemical group OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 29
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 24
- 230000002421 anti-septic effect Effects 0.000 claims description 15
- 239000004014 plasticizer Substances 0.000 claims description 15
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 14
- 238000000034 method Methods 0.000 claims description 14
- 239000000227 bioadhesive Substances 0.000 claims description 13
- 229920000642 polymer Polymers 0.000 claims description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 claims description 10
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 claims description 10
- GYCKQBWUSACYIF-UHFFFAOYSA-N o-hydroxybenzoic acid ethyl ester Natural products CCOC(=O)C1=CC=CC=C1O GYCKQBWUSACYIF-UHFFFAOYSA-N 0.000 claims description 10
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 8
- 238000003756 stirring Methods 0.000 claims description 8
- 229920002125 Sokalan® Polymers 0.000 claims description 7
- AXTGDCSMTYGJND-UHFFFAOYSA-N 1-dodecylazepan-2-one Chemical group CCCCCCCCCCCCN1CCCCCC1=O AXTGDCSMTYGJND-UHFFFAOYSA-N 0.000 claims description 6
- 229960001631 carbomer Drugs 0.000 claims description 5
- -1 poly-alkyl sucrose Chemical compound 0.000 claims description 5
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 4
- DOIRQSBPFJWKBE-UHFFFAOYSA-N dibutyl phthalate Chemical compound CCCCOC(=O)C1=CC=CC=C1C(=O)OCCCC DOIRQSBPFJWKBE-UHFFFAOYSA-N 0.000 claims description 4
- 230000008569 process Effects 0.000 claims description 4
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 claims description 4
- 239000000725 suspension Substances 0.000 claims description 4
- 230000008961 swelling Effects 0.000 claims description 4
- 238000005303 weighing Methods 0.000 claims description 4
- 239000000084 colloidal system Substances 0.000 claims description 3
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 2
- 229930006000 Sucrose Natural products 0.000 claims description 2
- 239000004202 carbamide Substances 0.000 claims description 2
- 235000013877 carbamide Nutrition 0.000 claims description 2
- 229920001577 copolymer Polymers 0.000 claims description 2
- 238000004132 cross linking Methods 0.000 claims description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 claims description 2
- 229940059574 pentaerithrityl Drugs 0.000 claims description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 2
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 claims description 2
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 claims description 2
- 229960003415 propylparaben Drugs 0.000 claims description 2
- 239000005720 sucrose Substances 0.000 claims description 2
- 238000010521 absorption reaction Methods 0.000 claims 1
- 239000003623 enhancer Substances 0.000 claims 1
- 239000003364 biologic glue Substances 0.000 abstract description 9
- 239000000463 material Substances 0.000 abstract description 5
- 208000015181 infectious disease Diseases 0.000 abstract description 4
- 229940079593 drug Drugs 0.000 abstract description 3
- 239000007888 film coating Substances 0.000 abstract 3
- 238000009501 film coating Methods 0.000 abstract 3
- LDZSKLOBVMBMRH-UHFFFAOYSA-N 2-benzyl-1H-pyrrole 1,1'-biphenyl Chemical class C(C1=CC=CC=C1)C=1NC=CC1.C1(=CC=CC=C1)C1=CC=CC=C1 LDZSKLOBVMBMRH-UHFFFAOYSA-N 0.000 abstract 2
- 108010025899 gelatin film Proteins 0.000 abstract 1
- 239000000499 gel Substances 0.000 description 24
- 239000010408 film Substances 0.000 description 18
- 238000012856 packing Methods 0.000 description 9
- 206010017533 Fungal infection Diseases 0.000 description 8
- 208000031888 Mycoses Diseases 0.000 description 8
- 235000011187 glycerol Nutrition 0.000 description 8
- 230000000694 effects Effects 0.000 description 6
- WLAMNBDJUVNPJU-UHFFFAOYSA-N 2-methylbutyric acid Chemical compound CCC(C)C(O)=O WLAMNBDJUVNPJU-UHFFFAOYSA-N 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 229940082484 carbomer-934 Drugs 0.000 description 3
- 239000012467 final product Substances 0.000 description 3
- 239000002674 ointment Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000010409 thin film Substances 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 206010005913 Body tinea Diseases 0.000 description 2
- 206010048768 Dermatosis Diseases 0.000 description 2
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 2
- 208000002474 Tinea Diseases 0.000 description 2
- 208000007712 Tinea Versicolor Diseases 0.000 description 2
- 201000010618 Tinea cruris Diseases 0.000 description 2
- 206010067197 Tinea manuum Diseases 0.000 description 2
- 206010056131 Tinea versicolour Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000000843 anti-fungal effect Effects 0.000 description 2
- 229940121375 antifungal agent Drugs 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 210000000416 exudates and transudate Anatomy 0.000 description 2
- 230000002538 fungal effect Effects 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical compound CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 2
- 208000017520 skin disease Diseases 0.000 description 2
- 201000003875 tinea corporis Diseases 0.000 description 2
- 201000004647 tinea pedis Diseases 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010027336 Menstruation delayed Diseases 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229940049638 carbomer homopolymer type c Drugs 0.000 description 1
- 229940043234 carbomer-940 Drugs 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000003670 easy-to-clean Effects 0.000 description 1
- 210000004905 finger nail Anatomy 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 150000002460 imidazoles Chemical class 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- BGKFMRKZNTYDQB-UHFFFAOYSA-N propane-1,1-diol;propane-1,2,3-triol Chemical compound CCC(O)O.OCC(O)CO BGKFMRKZNTYDQB-UHFFFAOYSA-N 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- FQXXSQDCDRQNQE-VMDGZTHMSA-N thebaine Chemical class C([C@@H](N(CC1)C)C2=CC=C3OC)C4=CC=C(OC)C5=C4[C@@]21[C@H]3O5 FQXXSQDCDRQNQE-VMDGZTHMSA-N 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 239000012049 topical pharmaceutical composition Substances 0.000 description 1
- 150000003852 triazoles Chemical class 0.000 description 1
Abstract
Description
成分 | 数量%重量 |
联苯苄唑 | 1 |
PVA04-86 | 6.7 |
PVA17-88 | 6.7 |
卡波姆940 | 1 |
甘油 | 3.3 |
丙二醇 | 5 |
氮酮 | 2 |
尼泊金乙酯 | 0.1 |
乙醇 | 13 |
水 | 61.2 |
总计 | 100 |
成分 | 数量%重量 |
联苯苄唑 | 1 |
PVA04-86 | 5 |
卡波姆934 | 3 |
甘油 | 3 |
丙二醇 | 5 |
氮酮 | 2 |
尼泊金乙酯 | 0.1 |
95%乙醇 | 余量 |
成分 | 数量%重量 |
联苯苄唑 | 1 |
PVA04-86 | 2 |
PVA17-88 | 6 |
卡波姆940 | 2 |
甘油 | 6 |
二甲基亚砜 | 0.4 |
尼泊金乙酯 | 0.1 |
乙醇 | 26 |
水 | 适量 |
成分 | 数量%重量 |
联苯苄唑 | 1 |
PVA17-88 | 15 |
卡波姆940 | 1 |
甘油 | 7.5 |
二甲基亚砜 | 0.4 |
尼泊金乙酯 | 0.1 |
乙醇 | 30 |
水 | 适量 |
成分 | 数量%重量 |
联苯苄唑 | 1 |
PVA17-88 | 15 |
卡波姆940 | 1 |
甘油 | 3 |
二甲基亚砜 | 0.4 |
尼泊金乙酯 | 0.1 |
乙醇 | 30 |
水 | 适量 |
成分 | 数量%重量 |
联苯苄唑 | 1 |
PVA124 | 10 |
卡波姆934 | 1 |
甘油 | 5 |
二甲基亚砜 | 0.4 |
尼泊金乙酯 | 0.1 |
乙醇 | 20 |
水 | 适量 |
Claims (13)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200410039087 CN1286459C (zh) | 2003-08-06 | 2004-02-02 | 一种含联苯苄唑的透明、隐形的外用药物制剂 |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNA031497721A CN1480128A (zh) | 2003-08-06 | 2003-08-06 | 一种透明、隐形的外用药物制剂 |
CN03149772.1 | 2003-08-06 | ||
CN 200410039087 CN1286459C (zh) | 2003-08-06 | 2004-02-02 | 一种含联苯苄唑的透明、隐形的外用药物制剂 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1579393A CN1579393A (zh) | 2005-02-16 |
CN1286459C true CN1286459C (zh) | 2006-11-29 |
Family
ID=34593085
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 200410039087 Expired - Lifetime CN1286459C (zh) | 2003-08-06 | 2004-02-02 | 一种含联苯苄唑的透明、隐形的外用药物制剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1286459C (zh) |
-
2004
- 2004-02-02 CN CN 200410039087 patent/CN1286459C/zh not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
CN1579393A (zh) | 2005-02-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0247142B1 (en) | Film-forming, pharmaceutical vehicles for application of medicaments to nails, pharmaceutical compositions based on those vehicles, and methods of using same | |
CA2341814C (en) | Controlled delivery system of antifungal and keratolytic agents for local treatment of fungal infections of the nail and surrounding tissues | |
CN1200673C (zh) | 抗真菌指甲油组合物 | |
KR101333892B1 (ko) | 항진균 조성물 | |
CN1316965C (zh) | 一种透明、隐形的外用给药载体 | |
US20060105057A1 (en) | Compositions using tetrasilver tetroxide and methods for management of skin conditions using same | |
CN1899291A (zh) | 外用抗真菌的复方组合物及其应用 | |
CN101053565A (zh) | 一种含有克霉唑的阴道片 | |
CN1286459C (zh) | 一种含联苯苄唑的透明、隐形的外用药物制剂 | |
CN108210462A (zh) | 一种克立硼罗局部缓释脂质体的制法与应用 | |
CN1771981A (zh) | 一种痔疮膏 | |
KR20130087379A (ko) | 1-아미노-알킬시클로헥산 유도체의 국소 사용을 위한 겔 제형 | |
RU2536266C2 (ru) | Крем медицинского назначения, изготовленный с использованием фрамицетина сульфата и хитозана, и способ его изготовления | |
US20200237705A1 (en) | Method to treat antimicrobial resistant candida | |
CN1279944A (zh) | 一种治疗阴道炎的泡腾片剂及其制法 | |
CN1221264C (zh) | 一种治疗带状疱疹的局部给药的药物组合物 | |
US8257688B2 (en) | Controlled delivery system of antifungal and keratolytic agents for local treatment of fungal infections of the nail and surrounding tissues | |
CN1063632C (zh) | 一种治疗皮肤病的外用搽剂 | |
CN101049286A (zh) | 含环吡酮胺的凝胶制剂 | |
RU2311186C1 (ru) | Биологически активный компонент, обладающий противогрибковым действием, и противогрибковый лечебно-косметический лак демиктен на его основе | |
RU2431497C1 (ru) | Комбинированное лекарственное средство, обладающее противогрибковым, противовирусным, противомикробным, противовоспалительным, иммуномодулирующим и бактерицидным действием для наружного или локального применения | |
CN1539410A (zh) | 一种治疗乳房疾病的外用药组合物及其制备方法 | |
CN117462490A (zh) | 一种阿莫罗芬搽剂 | |
CN111701013A (zh) | 一种具有治疗真菌感染的外用药物及制备方法 | |
RU2292198C1 (ru) | Средство лечения грибковых заболеваний кожи широкого спектра действия |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Assignee: HAINAN YANGSHENGTANG PHARMACEUTICAL Co.,Ltd. Assignor: YANG SHENG TANG Co.,Ltd. Contract fulfillment period: 2008.9.25 to 2013.9.24 Contract record no.: 2008460000019 Denomination of invention: Transparaent and disappearing external medicine preparation containing benzotolazo Granted publication date: 20061129 License type: Exclusive license Record date: 20081113 |
|
LIC | Patent licence contract for exploitation submitted for record |
Free format text: EXCLUSIVE LICENSE; TIME LIMIT OF IMPLEMENTING CONTACT: 2008.9.25 TO 2013.9.24; CHANGE OF CONTRACT Name of requester: HAINAN YANGSHENGTANG PHARMACEUTICAL CO., LTD. Effective date: 20081113 |
|
CX01 | Expiry of patent term | ||
CX01 | Expiry of patent term |
Granted publication date: 20061129 |